- 1. Guan W.J., Ni Z.Y., Hu Y. et al. (2020) Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med., 382: 1708–1720.
- 2. Huang C., Wang Y., Li X. et al. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395: 497–506.
- 3. Deng S.-Q., Peng H.-J. (2020) Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J. Clin. Med., 9(2): 575.
- 4. Peng Y. D., Meng K., Guan H.Q. et al. (2020) Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV. Chinese J. Cardiol., 48(6): 450–455.
- 5. Zhou F., Yu T., Du R. et al. (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 395: 1054–1062.
- 6. Campbell-Scherer D. (2010) Multimorbidity: a challenge for evidencebased medicine. Evid. Based Med., 15: 165–166. doi: 10.1136/ebm1154.
- 7. Caughey G.E., Ramsay E.N., Vitry A.I. et al. (2010) Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study. Community Health, 64: 1036–1042.
- 8. Marrie R.A., Rudick R., Horwitz R. et al. (2010) Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurol., 74: 1041–1047. doi: 10.1212/ WNL.0b013e3181d6b125.
|